Joint Meeting of the

ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE AND

THE DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE

 November 17, 2000

Federal Register Notice November 17, 2000 Meeting   pdf   htm

FDA Background Information  pdf  doc

Draft Guidance for Industry: Topical Dermatological Drug Product NDAs and ANDAs -- In Vivo Bioavailability, Bioequivalence, In Vitro Release, and Associated Studies, June 1998